FDAMon Oct 27, 2025
In the five trading days before BMY's news on Oct 27 (Data: Deucravacitinib), traders put $932K into large options bets, mostly calls, which pay off if the stock rises. Foreshadow rates that about normal: 18 out of 100. Options were pricing in a move of about 0.6%. The stock fell 1.0%, against the bets, so they were wrong.
That betting was busier than 65% of 587 finished FDA cases, and busier than 5 of BMY's 6 other finished cases.
The line is the stock price. Under it is each measurement that goes into the score. The yellow days are the five that count; the faded ones show what's normal for this stock. The number at the right of each row is how many of the 100 points it added.
Watch the betting build up, one trading day at a time.
Hover over a day to see its numbers, or select the chart and use the arrow keys.
A normal day for this stock, over the 60 days before, saw about $251K in large options bets.
8 large options trades were flagged in these five days, worth $1.1M in total. $932K of it was bought at the asking price; those are the bets. The rest was sold or traded between the two prices. A call pays off if the stock rises above its price; a put pays off if it falls below.
| Trade | Strike, expiry | Day | Amount |
|---|---|---|---|
| Callbought | $45, Oct 31 '25Tue Oct 21 | Tue Oct 21Filled fast across exchanges | $215K |
| Putbought | $45, Jan 16 '26Wed Oct 22 | Wed Oct 22 | $213K |
| Callbought | $45, Oct 31 '25Tue Oct 21 | Tue Oct 21Filled fast across exchanges |
Of 65 finished FDA cases that scored 10 to 26 with bets leaning toward a rise, the bets were right in 5 (8%), and the stock at least moved the way they leaned in 33 (51%).
| $173K |
| Putsold | $40, Dec 18 '26Wed Oct 22 | Wed Oct 22 | $151K |
| Callbought | $46, Oct 31 '25Tue Oct 21 | Tue Oct 21Filled fast across exchanges | $115K |
| Putbought | $45, Jan 16 '26Wed Oct 22 | Wed Oct 22 | $91K |
| Callbought | $46.5, Oct 31 '25Thu Oct 23 | Thu Oct 23Filled fast across exchanges | $67K |
| Callbought | $47, Mar 20 '26Fri Oct 24 | Fri Oct 24 | $59K |
These trades are a sample from Unusual Whales data. The full details live on Unusual Whales.
Each measurement is compared with this stock's normal 60 days. The further above normal, the more points it earns, up to its maximum. The points add up to the score. For the formula, see How it works.
How much was bet
$217K/day vs $251K normally, 1.6 vs 2.3 alerts/day, 50% sweeps
+2.6 of 25
How one-sided the bets were
net ask-side +$65K/day vs −$2K, calls $628K, puts $455K
+2.1 of 20
New contracts opened
26,703 contracts/day vs 20,391, calls +83,953, puts +29,340
+3.0 of 20
Options volume vs. normal
69th percentile on average, peak 78, baseline 56
+10.3 of 15
Change in the cost of protection
put−call IV -1.5 → -0.8 pts, typical 5-day move ±0.0
+0.0 of 10
Big off-exchange stock trades
$0/day in prints ≥ $1M vs $22.0M, 0 prints
+0.0 of 10
Built from seven kinds of Unusual Whales data for BMY: large options trades (flow alerts), new open interest, options volume, the put and call price gap (skew), dark-pool prints, daily prices and the expected move. What each one measures
Short answers from this case's data and Unusual Whales, written by Claude.